Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

St. Vincent’s Hospital Implants Australia’s 1st SynCardia Total Artificial Heart

August 18, 2010 By SynCardia

Sydney Hospital to Serve as SynCardia’s Regional
Certification Center for Asia-Pacific
Aug. 16, 2010: Angelo Tigano, the first patient to receive the SynCardia temporary Total Artificial Heart in the Southern Hemisphere, at a news conference at St. Vincent’s Hospital in Sydney, Australia.


Aug. 16, 2010: Angelo Tigano, the first patient to receive the
SynCardia temporary Total Artificial Heart in the Southern
Hemisphere, at a news conference at St. Vincent’s Hospital in
Sydney, Australia.

TUCSON, Ariz. – Aug. 19, 2010 – On
Aug. 5, St. Vincent’s Hospital in Sydney performed
Australia’s first implant of the SynCardia temporary Total
Artificial Heart. The patient, a 50-year-old-male suffering from
total heart failure, is the first recipient of the Total Artificial
Heart in the Southern Hemisphere. The surgery was performed by
heart surgeons Drs. Phillip Spratt and Paul Jansz. View extensive
Media Coverage

“At any one time there can be around 30 people waiting for
a heart transplant at our hospital,” said Dr. Spratt, Head of
the St. Vincent’s Hospital Heart/Lung Transplant Unit.
“We selected this patient to receive the Total Artificial
Heart as a bridge-to-transplant because without it, he would have
had less than two weeks to live.”

Angelo Tigano had suffered from idiopathic cardiomyopathy for
more than a decade. Walking more than a few steps left him gasping
for breath, until finally he was unable to eat or sleep. Mr. Tigano
says he hopes the Total Artificial Heart will improve his quality
of life and allow him to return to some of the normal activities he
did before suffering heart failure.  

“The Total Artificial Heart has no equal,” said Dr.
Spratt, who led the Total Artificial Heart implant surgery.
“Unlike a left ventricular assist device (LVAD), which helps
the failing left ventricle, the Total Artificial Heart replaces
both the left and right heart ventricles which are responsible for
pumping blood.”

The implant surgery was proctored by world renowned heart
surgeon Dr. Jack Copeland, who recently joined the faculty at the
University of California, San Diego, and has performed more than
100 implants of the Total Artificial Heart. St. Vincent’s
Hospital is the 31st hospital in the world to become a SynCardia Certified
Center
. Currently, there are Certified Centers in the U.S.,
Canada, France, Germany, Italy, Sweden, Austria, Russia and now
Australia.

St. Vincent’s is the largest transplant hospital in
Australia and will serve as SynCardia’s Regional
Certification Center for the Asia-Pacific. Device Technologies is
the Australasian distributor of the SynCardia Total Artificial
Heart and is a major supplier of leading edge medical equipment and
consumables to hospitals and healthcare professionals throughout
Australia and New Zealand.

Cardiovascular disease is the leading cause of death in
Australia. Despite the increase in this condition and consequent
growing demand for transplants, the supply of donor hearts is
falling in Australia. In 2009, a total of 60 heart transplants took
place, compared with 82 in 2008. Australia has one of the lowest
donation rates in the developed world with only 12 donors per
million in 2008.

Source: http://www.donatelife.gov.au/Discover/Facts-and-Statistics.htm

###

About SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the
world’s only FDA, Health Canada and CE approved Total
Artificial Heart: the SynCardia temporary Total Artificial Heart.
There have been more than 850 implants of the Total Artificial
Heart, accounting for more than 200 patient years of life on the
device. 

Originally used as a permanent replacement heart, the Total
Artificial Heart is currently approved as a bridge to human heart
transplant for people dying from end-stage biventricular
failure. The Total Artificial Heart is the only device that
provides immediate, safe blood flow of up to 9.5 L/min through
both ventricles.

Sign-up to
receive the latest news updates from SynCardia

For additional information, please visit: http://www.syncardia.com

or follow SynCardia on Twitter – @SynCardia_News

 

Media Contact:


Don Isaacs

Vice President of Communications

SynCardia Systems, Inc.

Cell: (520) 955-0660

 

 

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech